The COVID-19 induced lockdown has led to a delay in several entrance examinations. Keeping in view that it will be difficult to conduct exams offline due to social distancing measures, the All India Management Association (AIMA) has decided to conduct it's Management Aptitude Test (MAT) online through remote proctoring.
Management Aptitude Test (MAT) is a standardised test administered by AIMA to facilitate business schools to screen candidates for admission to MBA and allied programs. The Union Ministry of Human Resource and Development (MHRD) approved MAT as a national level test in 2003.
Over 600 business schools consider MAT Score as an admission input, based on the scorecards issued to the candidates.
In light of the coronavirus crisis, AIMA has added the option of MAT in “Remote Proctoring Internet Based Test (IBT)” mode. In this mode, candidates can appear for the test from their homes subject to certain norms. If they have a computer with webcam and internet connectivity conforming to the technical specifications, they are eligible for appearing for the test.
The candidates would be proctored remotely using Artificial Intelligence (AI) based tools.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
AIMA also plans to make this technology available for descriptive tests conducted by it across India for students enrolled in its distance education management programs such as PGDM, PGDITM, etc.